Infliximab infusion is not yet FDA-approved for psoriasis but has been reported to be very effective for plaque psoriasis. We report 2 patients without a history of psoriasis who after administration of infliximab for their inflammatory bowel disease experienced new onset, biopsy confirmed psoriasis.
|Original language||English (US)|
|Number of pages||2|
|Journal||Journal of drugs in dermatology : JDD|
|State||Published - Feb 2006|
All Science Journal Classification (ASJC) codes